Veeva Systems (NYSE:VEEV) Earns Buy Rating from Analysts at Guggenheim

Posted by Geri Gentry on Jul 26th, 2026

Guggenheim started coverage on shares of Veeva Systems (NYSE:VEEV – Free Report) in a report issued on Thursday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $232.00 target price on the technology company’s stock.

VEEV has been the subject of a number of other reports. Wells Fargo & Company raised their price target on Veeva Systems from $317.00 to $320.00 and gave the company an “overweight” rating in a research note on Thursday, June 4th. The Goldman Sachs Group dropped their price objective on Veeva Systems from $190.00 to $165.00 and set a “sell” rating on the stock in a research note on Thursday, June 4th. Canaccord Genuity Group cut their price objective on Veeva Systems from $235.00 to $220.00 and set a “hold” rating for the company in a report on Thursday, June 4th. Citigroup raised their target price on shares of Veeva Systems from $176.00 to $190.00 and gave the company a “neutral” rating in a research note on Thursday, June 4th. Finally, Raymond James Financial restated an “outperform” rating and set a $225.00 target price on shares of Veeva Systems in a report on Thursday, June 4th. One analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $247.08.

Check Out Our Latest Research Report on Veeva Systems

Veeva Systems Price Performance

Veeva Systems stock opened at $186.06 on Thursday. The company has a market cap of $30.22 billion, a price-to-earnings ratio of 33.17, a P/E/G ratio of 0.80 and a beta of 0.94. The firm has a 50-day moving average of $174.59 and a 200-day moving average of $181.60. Veeva Systems has a one year low of $148.05 and a one year high of $310.50.

Veeva Systems (NYSE:VEEV – Get Free Report) last released its earnings results on Wednesday, June 3rd. The technology company reported $2.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.The business had revenue of $882.95 million for the quarter, compared to the consensus estimate of $857.73 million. During the same quarter in the previous year, the business earned $1.97 earnings per share. Veeva Systems’s quarterly revenue was up 16.3% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. As a group, sell-side analysts expect that Veeva Systems will post 6.65 earnings per share for the current year.

Insiders Place Their Bets

In other Veeva Systems news, Director Priscilla Hung sold 750 shares of the company’s stock in a transaction that occurred on Thursday, April 30th. The stock was sold at an average price of $155.64, for a total value of $116,730.00. Following the sale, the director owned 3,253 shares in the company, valued at $506,296.92. This represents a 18.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. SHP Wealth Management bought a new stake in Veeva Systems in the 4th quarter valued at $26,000. Newbridge Financial Services Group Inc. boosted its position in Veeva Systems by 322.6% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company’s stock worth $29,000 after purchasing an additional 100 shares during the period. Activest Wealth Management boosted its position in Veeva Systems by 3,175.0% during the fourth quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock worth $29,000 after purchasing an additional 127 shares during the period. MV Capital Management Inc. acquired a new position in shares of Veeva Systems in the fourth quarter valued at $30,000. Finally, Reflection Asset Management acquired a new position in shares of Veeva Systems in the fourth quarter valued at $32,000. 88.20% of the stock is currently owned by institutional investors.

Key Headlines Impacting Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

Positive Sentiment: Guggenheim upgraded Veeva Systems to strong-buy and later set a $232 price target, implying meaningful upside from current levels. Tickerreport.com
Positive Sentiment: Investor interest is being supported by articles highlighting Veeva as a cash-heavy stock with financial stability, which may appeal to defensive growth investors. Yahoo Finance
Positive Sentiment: Recent commentary points to steady execution and attractive P/E multiples, reinforcing the view that Veeva’s fundamentals remain solid ahead of its next earnings report. Seeking Alpha
Neutral Sentiment: Several recent articles focus on what to expect from Veeva’s next earnings release and broader analyst sentiment, suggesting the stock may remain sensitive to upcoming guidance and results. MSN
Negative Sentiment: The stock had recently declined more than the broader market, reminding investors that near-term volatility remains a risk despite the positive analyst coverage. Yahoo Finance

About Veeva Systems

(Get Free Report)

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.